Haemonetics(FRA) HAZ

Market Cap€4.05B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€88.00

-1.12%

-1.00Today

Haemonetics Financials at a Glance

Market Cap

€4.05B

Revenue (TTM)

€1.16K

Net Income (TTM)

€82.71

EPS (TTM)

€1.76

P/E Ratio

50.53

Dividend

€0.00

Beta (Volatility)

-0.02 (Low)

Dividend

€0.00

Beta (Volatility)

-0.02 (Low)

Price

€88.00

Volume

Open

€88.00

Price

€88.00

Volume

Open

€88.00

Previous Close

€88.00

Daily Range

€88.00 - €88.00

52-Week Range

€39.80 - €94.50

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

-0.02 (Low)

Price

€88.00

Volume

Open

€88.00

Previous Close

€88.00

Daily Range

€88.00 - €88.00

52-Week Range

€39.80 - €94.50

Estimated Earnings Date

N/A

HAZ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Haemonetics

Haemonetics Corp. is a global healthcare company, which engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

3,009

CEO

Christopher A. Simon, MBA

Website

www.haemonetics.com

HAZ Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

11.15%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

1.98%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€4.05B

Shares Outstanding

45.50M

Volume

Avg. Volume

3.061

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Haemonetics Performance Analysis

Haemonetics annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2023	2023-03-31	EUR 1,123,469,451	31.4%
2024	2024-03-31	EUR 1,207,337,307	7.5%
2025	2025-03-31	EUR 1,267,583,020	5.0%
2026	2026-03-31	EUR 1,151,290,772	-9.2%

Haemonetics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2023	2023-03-31	EUR 2.16	196.7%
2024	2024-03-31	EUR 2.11	-2.2%
2025	2025-03-31	EUR 3.08	45.9%
2026	2026-03-31	EUR 1.77	-42.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€291.89

+1.0%

Gross Profit

€166.32

+1.0%

Gross Margin

56.98%

+1.0%

Market Cap

€4.05B

N/A

Market Cap/Employee

€0.98

N/A

Employees

3,009

N/A

Net Income

€28.39

+0.9%

EBITDA

€74.71

+1.0%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€1.22K

-5.5%

Total Debt

€1.03K

+1.0%

Accounts Receivable

€188.99

+1.1%

Inventory

€268.29

+0.9%

Long Term Debt

€1.02K

+1.3%

Short Term Debt

€4.33

+0.0%

Return on Assets

3.97%

+0.6%

Return on Invested Capital

6.22%

N/A

Free Cash Flow

€38.20

+3.2%

Operating Cash Flow

€45.00

+2.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About HAZ

What is the current price of Haemonetics?

Haemonetics is trading at €88.00 per share.

What is the 52-week range for Haemonetics?

Over the past 52 weeks, Haemonetics has traded between €39.80 and €94.50.

How much debt does Haemonetics have?

As of the most recent reporting period, Haemonetics reported total debt of €1.03B.

How much cash does Haemonetics have on hand?

Haemonetics reported €195.39M in cash and cash equivalents in its most recent financial results.

What is Haemonetics’s dividend yield?

Haemonetics does not currently have a dividend yield.

Haemonetics(FRA) HAZ

Haemonetics Financials at a Glance

HAZ News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Haemonetics

HAZ Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Haemonetics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HAZ

What is the current price of Haemonetics?

What is the 52-week range for Haemonetics?

How much debt does Haemonetics have?

How much cash does Haemonetics have on hand?

What is Haemonetics’s dividend yield?

Premium Investing Services